Injecto Polymers Ltd IPO opens for subscription on September 11, 2026 and closes on September 16, 2026. The issue is proposed to list on the BSE SME platform, with the tentative listing expected on September 21, 2026. The IPO is a fresh issue of up to 56,12,400 equity shares, which means the proceeds will go to the company rather than existing shareholders.
The company plans to use the IPO proceeds mainly for repayment or prepayment of borrowings, Phase IV expansion at its Unit-I facility in Jaugram, West Bengal, and general corporate purposes. This makes the IPO important not just as a listing opportunity, but also as a funding event that could influence the company’s capacity, debt profile and future growth.
Injecto Polymers Limited operates in the plastic packaging and polymer products space. The company manufactures products such as PP woven bags, BOPP bags, FIBC bags, Leno bags, pouches and non-woven bags, and also trades in plastic granules and PVC resins. These products serve industries such as agriculture, construction, textiles, food, chemicals, pharmaceuticals and consumer goods.
This guide explains the IPO details, business model, financial performance, GMP, key risks and practical checks investors should understand before applying.
Injecto Polymers IPO at a Glance
| IPO Detail | Information |
| Company | Injecto Polymers Limited |
| IPO type | BSE SME IPO |
| Issue type | 100% Book Built Issue |
| Fresh issue | Up to 56,12,400 equity shares |
| Offer for Sale | Not applicable |
| IPO opening date | September 11, 2026 |
| IPO closing date | September 16, 2026 |
| Tentative listing date | September 21, 2026 |
| Listing platform | BSE SME |
| Lead manager | Indcap Advisors Private Limited |
| Registrar | Integrated Registry Management Services Private Limited |
| Market maker | CapitalSquare Financial Services Pvt. Ltd. |
| Face value | ₹10 per share |
About Injecto Polymers Ltd
Injecto Polymers Limited was originally incorporated in September 1998 as Injecto Polymers Private Limited and later converted into a public limited company in July 2024. The company’s registered office is in Kolkata, West Bengal. The RHP identifies Ramesh Kumar Rateria, Ashok Kumar Rateria, Suman Financial Advisory Private Limited, Suman Towers Private Limited, Vinayak Tie-Up Private Limited, Nivedeeka Commercial Private Limited and Bhagyashri Trading Private Limited as promoters.
The company operates in two connected areas: manufacturing of plastic packaging products and trading of polymer raw materials such as plastic granules and PVC resins. Its product portfolio includes Polypropylene woven fabrics, PP woven bags, BOPP bags, Leno bags, low-density and polyester pouches, FIBC bags and non-woven bags. These products are used across industries such as agriculture, construction, textiles, chemicals, food, pharmaceuticals, cosmetics and consumer goods.
This business model gives Injecto Polymers exposure to India’s packaging demand, industrial activity and polymer consumption. However, it also exposes the company to raw material price volatility, working-capital pressure and competition from other packaging manufacturers.
In simple words, Injecto Polymers is not a consumer brand IPO. It is a B2B packaging and polymer business where investor returns will depend on capacity utilisation, margins, debt management, customer demand, input costs and post-listing valuation.
Financial Performance
Injecto Polymers has reported strong growth in recent years. A2Z IPO’s financial table shows total income rising from ₹109.80 crore in FY2024 to ₹261.85 crore in FY2025 and ₹375.83 crore in FY2026. Profit after tax increased from ₹4.44 crore in FY2024 to ₹8.11 crore in FY2025 and ₹16.01 crore in FY2026.
| Financial Metric | FY2024 | FY2025 | FY2026 |
| Total income | ₹109.80 crore | ₹261.85 crore | ₹375.83 crore |
| Profit after tax | ₹4.44 crore | ₹8.11 crore | ₹16.01 crore |
| EBITDA | ₹12.35 crore | ₹22.57 crore | ₹38.04 crore |
| Net worth | ₹21.22 crore | ₹47.33 crore | ₹63.34 crore |
| Total borrowings | ₹83.35 crore | ₹101.11 crore | ₹165.19 crore |
The growth is impressive, but investors should not stop at the revenue and PAT trend. Total borrowings have also increased materially. The RHP states that as of March 31, 2026, the company had total borrowings of ₹16,518.69 lakh, and it proposes to use up to ₹1,000 lakh from IPO proceeds for repayment or prepayment of borrowings.
This creates a balanced view. Injecto Polymers is growing, but that growth appears capital-intensive and working-capital-heavy. Investors should ask whether the company can maintain margins while expanding capacity and managing debt.
The RHP also notes that total interest cost increased by 41.22% in FY2026 compared with FY2025, mainly due to higher working-capital utilisation and incremental borrowings to support operational requirements.
Business Strengths of Injecto Polymers?
1. Established Operating History
Injecto Polymers has more than two decades of operating history. In SME IPOs, longevity matters because it suggests the company has survived different market cycles, customer requirements and input cost environments.
2. Diversified Product Portfolio
The company manufactures several packaging formats, including PP woven fabrics, woven bags, BOPP bags, FIBC bags, Leno bags and pouches. A wider product range may help the company serve different industries and reduce dependence on a single packaging product.
3. Fresh Issue for Expansion
The IPO proceeds are planned partly for Phase IV expansion and debt repayment. If the company executes the expansion well, higher capacity could support future revenue growth. The planned 4,800 MT per annum additional capacity is a key factor investors should track after listing.
4. Exposure to Packaging Demand
Plastic packaging is used in agriculture, construction, food, chemicals, textiles, consumer goods and other sectors. This gives the company exposure to broad industrial and consumption-linked demand.
5. Improved Profitability
The company’s PAT has increased from ₹4.44 crore in FY2024 to ₹16.01 crore in FY2026, according to available IPO data. This trend may attract growth-focused investors, but it should be studied along with debt, margins and cash flows.
Key Risks Investors Should Not Ignore
1. High Borrowings
The company’s borrowings are significant compared with its net worth. Total borrowings stood at ₹165.19 crore in FY2026, while net worth was ₹63.34 crore, according to available financial data.
This is important because debt can amplify both growth and risk. If sales growth slows or margins fall, finance costs may pressure profitability.
2. Raw Material Price Volatility
Injecto Polymers uses and trades polymer-related materials such as plastic granules and PVC resins. Polymer prices can be influenced by crude oil prices, demand-supply conditions, imports, logistics and currency movement. If the company cannot pass higher input costs to customers quickly, margins may suffer.
3. Working-Capital Intensity
Manufacturing and trading businesses often require inventory, receivables and credit lines. The RHP discussion on interest cost indicates increased utilisation of working-capital facilities in FY2026 due to higher operational requirements.
4. Related-Party Transaction Disclosure Lapses
The RHP states that certain related-party transactions were not specifically disclosed in earlier financial statements in accordance with Schedule III disclosure requirements. The RHP also provides reconciliation details after incorporating previously unreported transactions.This does not automatically mean investors should avoid the IPO, but it is an important governance point. Investors should read this risk carefully and decide whether they are comfortable with the disclosure history.
5. SME IPO Liquidity Risk
SME IPOs can have limited liquidity after listing. The RHP itself warns that there has been no formal market for the company’s equity shares and that no assurance can be given regarding active or sustained trading after listing. This matters because investors may not always be able to exit easily at a desired price.
6. Expansion Execution Risk
The company is using IPO proceeds for Phase IV expansion. Expansion can create growth, but only if the company completes the project on time, controls costs, secures demand and maintains margins. Delays or underutilisation can affect returns.
Injecto Polymers Ltd IPO GMP Today
GMP, or grey market premium, is one of the most searched terms for SME IPOs. It reflects unofficial market sentiment before listing. However, GMP is not regulated by SEBI, NSE or BSE and should not be treated as a guaranteed listing price.
As of the latest data visible on several IPO tracking pages, Injecto Polymers Ltd IPO GMP was shown as ₹0 on some platforms. A2Z IPO and InvestorGain both displayed ₹0 GMP at the time of crawl.
A zero GMP does not automatically mean the IPO is bad. Similarly, a high GMP does not automatically mean an IPO is safe. Investors should use GMP only as a sentiment indicator, not as the main investment reason. For more clarity, you can read Acumen’s guide on what GMP means in IPO.
Conclusion
Injecto Polymers Ltd IPO gives investors exposure to a plastic packaging and polymer products company with an established operating history, rising revenue, improving profitability and fresh issue proceeds planned for debt repayment and capacity expansion. On paper, these are positive factors because the IPO money is expected to support the company’s business rather than provide an exit to existing shareholders.
However, investors should not look at growth alone. Injecto Polymers operates in a competitive, working-capital-heavy business where borrowings, raw material price volatility, customer demand, expansion execution and SME listing liquidity can affect future returns. The company’s planned Phase IV expansion may support scale, but investors should track whether higher capacity actually converts into profitable sales and stronger cash flows after listing.
A disciplined IPO decision should come from business understanding, not market noise. Before applying, read the RHP, check the latest price band and lot size, review the use of proceeds, compare valuation with financial performance, and invest only if the opportunity matches your personal investment plan. For broader investment discipline, read Acumen’s guides on how to analyze a company before investing, things you should know before investing and importance of risk management in stock market investing.
Key Definitions
Injecto Polymers IPO: Public issue of Injecto Polymers Limited on the BSE SME platform.
Fresh Issue: New shares issued by the company, where proceeds go to the company.
BSE SME: SME listing platform of BSE Limited.
RHP: Red Herring Prospectus containing IPO details, risks and financial information.
GMP: Grey Market Premium, an unofficial sentiment indicator before listing.
PP Woven Bags: Polypropylene packaging bags used in agriculture, industry and consumer sectors.
FIBC Bags: Bulk packaging bags used for large-volume industrial material handling.
PVC Resin: Polymer raw material used in plastic-related applications.
SME IPO Risk: Risk from lower liquidity, higher volatility and smaller company scale.
FAQs
1. What should I check first before applying for Injecto Polymers IPO?
First check whether the IPO proceeds are being used for business growth, debt repayment, or shareholder exit. In this case, the issue is a fresh issue, so investors should study how effectively the company can use funds for expansion and borrowing reduction.
2. Is Injecto Polymers IPO suitable for beginner investors?
Beginner investors should be careful because SME IPOs can be more volatile and less liquid than mainboard IPOs. Apply only after understanding the company’s financials, debt position, risks, and your ability to hold through price fluctuations.
3. Why does the company’s debt level matter to investors?
Debt matters because higher borrowings can reduce profits through interest costs, especially if sales growth slows or margins fall. Investors should check whether IPO funds meaningfully improve the company’s balance sheet after listing.
4. What makes Injecto Polymers IPO risky even if revenue is growing?
Revenue growth alone does not guarantee strong returns if the company faces raw material cost pressure, working-capital stress, or weak cash flows. Investors should compare profit growth with borrowings, margins, receivables, and operating cash flow.
5. How long should I be ready to hold after applying?
Investors should be prepared for post-listing volatility, especially because SME stocks may have lower trading liquidity. Apply only if you can hold beyond listing day and are not fully dependent on immediate listing gains.
Disclaimer:
This blog is intended for informational and educational purposes only and should not be considered investment advice or a recommendation to buy or sell any securities. Investments in the securities market are subject to market risks. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.
